Details for New Drug Application (NDA): 202686
✉ Email this page to a colleague
The generic ingredient in ESOMEPRAZOLE SODIUM is esomeprazole sodium. There are seventy-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the esomeprazole sodium profile page.
Summary for 202686
Tradename: | ESOMEPRAZOLE SODIUM |
Applicant: | Mylan |
Ingredient: | esomeprazole sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 20MG BASE/VIAL | ||||
Approval Date: | May 17, 2017 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 40MG BASE/VIAL | ||||
Approval Date: | May 17, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription